Clinical trials data
Verbal Fluency in stroke trials: 110 registered studies
Every registered stroke study on ClinicalTrials.gov that names Verbal Fluency in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered stroke studies name it in an outcome measure
- 110
- Name it in a primary outcome, 39%
- 43 of 110
Tests named in the same studies
- 1
Trail Making Test36 studies, 11 as a primary outcome
- 2
Digit Span Test31 studies, 10 as a primary outcome
- 3
Verbal Learning30 studies, 11 as a primary outcome
- 4
Picture Naming Test26 studies, 14 as a primary outcome
- 5
Stroop Color-Word Test25 studies, 7 as a primary outcome
- 6
Category Fluency24 studies, 9 as a primary outcome
- 7
Symbol Coding18 studies, 5 as a primary outcome
- 8
Cancellation Test9 studies, 1 as a primary outcome
- 9
Complex Figure Copy and Recall7 studies, 4 as a primary outcome
- 10
Token Commands Task7 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 3 | 1 |
| 2010 | 2 | 1 |
| 2011 | 1 | 1 |
| 2012 | 4 | 2 |
| 2013 | 2 | 1 |
| 2014 | 4 | 1 |
| 2015 | 5 | 1 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 12 | 4 |
| 2019 | 1 | 0 |
| 2020 | 12 | 5 |
| 2021 | 2 | 0 |
| 2022 | 4 | 0 |
| 2023 | 12 | 7 |
| 2024 | 9 | 4 |
| 2025 | 22 | 9 |
| 2026 | 6 | 2 |
Phases and study sizes
By phase
- Phase 11 studies, 1 as a primary outcome
- Phase 1/21 studies, 0 as a primary outcome
- Phase 26 studies, 2 as a primary outcome
- Phase 2/34 studies, 1 as a primary outcome
- Phase 32 studies, 0 as a primary outcome
- Phase 43 studies, 1 as a primary outcome
- Not applicable75 studies, 34 as a primary outcome
- Observational18 studies, 4 as a primary outcome
Participants per study
- Not applicable46 median, 25 to 80
- Observational175 median, 70 to 412
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 74 | 46 | 25 to 80 |
| Observational | 18 | 175 | 70 to 412 |
When stroke trials measure it
Latest time point of each outcome
- Within a day12 outcomes, 6 as a primary outcome
- Up to 4 weeks22 outcomes, 9 as a primary outcome
- 1 to 3 months27 outcomes, 12 as a primary outcome
- 3 to 6 months17 outcomes, 7 as a primary outcome
- 6 to 12 months13 outcomes, 4 as a primary outcome
- 1 to 2 years7 outcomes, 2 as a primary outcome
- Over 2 years5 outcomes, 1 as a primary outcome
- No duration given7 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
103 of the 110 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting26 studies, 10 as a primary outcome
- Not yet recruiting11 studies, 5 as a primary outcome
- Active, not recruiting6 studies, 1 as a primary outcome
- Completed43 studies, 20 as a primary outcome
- Stopped early5 studies, 2 as a primary outcome
- Status unknown19 studies, 5 as a primary outcome
What they test
- Behavioral32 studies, 15 as a primary outcome
- Drug12 studies, 4 as a primary outcome
- Device28 studies, 9 as a primary outcome
- Dietary supplement1 studies, 0 as a primary outcome
- Procedure8 studies, 3 as a primary outcome
- Diagnostic test5 studies, 2 as a primary outcome
- Biological3 studies, 0 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other38 studies, 21 as a primary outcome
- None given4 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States27 studies, 10 as a primary outcome
- Canada8 studies, 2 as a primary outcome
- China7 studies, 4 as a primary outcome
- France7 studies, 3 as a primary outcome
- Italy6 studies, 2 as a primary outcome
- Pakistan6 studies, 4 as a primary outcome
- Brazil5 studies, 0 as a primary outcome
- Switzerland5 studies, 1 as a primary outcome
- Taiwan4 studies, 3 as a primary outcome
- Germany3 studies, 1 as a primary outcome
- Netherlands3 studies, 0 as a primary outcome
- Singapore3 studies, 1 as a primary outcome
25 countries in all. A study with sites in several counts in each; 11 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed stroke studies that name Verbal Fluency: 22 of 43, 51%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed stroke studies that name Verbal Fluency | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 2% | 776, 10% |
| Results on ClinicalTrials.gov only | 11, 26% | 1,139, 14% |
| A results paper only | 10, 23% | 1,711, 22% |
| Neither | 21, 49% | 4,327, 54% |
The 110 studies
110 studies match. 43 name Verbal Fluency in a primary outcome. Median size 51 participants. Median time to the primary outcome: 12 weeks.
Loading 110 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 3 | 1 |
| 2010 | 2 | 1 |
| 2011 | 1 | 1 |
| 2012 | 4 | 2 |
| 2013 | 2 | 1 |
| 2014 | 4 | 1 |
| 2015 | 5 | 1 |
| 2016 | 2 | 1 |
| 2017 | 4 | 1 |
| 2018 | 12 | 4 |
| 2019 | 1 | 0 |
| 2020 | 12 | 5 |
| 2021 | 2 | 0 |
| 2022 | 4 | 0 |
| 2023 | 12 | 7 |
| 2024 | 9 | 4 |
| 2025 | 22 | 9 |
| 2026 | 6 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 8, other 102. Interventional 92, observational 18.
As a primary outcomeSecondary or other outcomeVerbal Fluency
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07792811 | Start2026 | PhasePhase 2/3 | ConditionsStroke | Participants84 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07759375 | Start2027 | PhaseNot applicable | ConditionsStroke | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07624630 | Start2026 | PhaseObservational | ConditionsStroke, Aging, frailty and exercise | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07588997 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants18 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07573501 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants24 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07573475 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants24 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07456475 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion, Parkinson's disease, Multiple sclerosis | Participants25 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07427511 | Start2026 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07346378 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07329751 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07281313 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07274748 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants52 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07253870 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants54 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07252544 | Start2025 | PhasePhase 3 | ConditionsStroke | Participants3,156 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07220538 | Start2025 | PhasePhase 4 | ConditionsStroke | Participants400 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07128823 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants60 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07119827 | Start2025 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants250 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07116187 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07030985 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants55 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07019493 | Start2025 | PhaseObservational | ConditionsStroke | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06950060 | Start2026 | PhaseNot applicable | ConditionsStroke, Aging, frailty and exercise | Participants48 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06927505 | Start2024 | PhaseNot applicable | ConditionsStroke | Participants58 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06927284 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants46 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06922409 | Start2025 | PhaseNot applicable | ConditionsStroke, Depression and bipolar disorder, Sleep and sleep disorders, Pain and fatigue | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06852209 | Start2025 | PhaseNot applicable | ConditionsStroke | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many stroke trials use Verbal Fluency?
110 registered stroke studies on ClinicalTrials.gov name it in an outcome measure, 43 of them in a primary outcome: 9% of the condition's 1,233 studies with a cognitive outcome, against 11% of all of them. It is the 2nd most named test in stroke trials.
Which tests do stroke trials use with Verbal Fluency?
The Trail Making Test (36 studies), the Digit Span Test (31 studies) and Verbal Learning (30 studies).
When do stroke trials measure Verbal Fluency?
Half of the primary outcomes that name Verbal Fluency are measured within 12 weeks of the start, and the middle half from 4 weeks to 6 months. 41 primary outcomes give a duration.
How many completed stroke trials that use Verbal Fluency have reported results?
22 of the 43 completed studies that name it, 51%, have reported results: 12 posted them on ClinicalTrials.gov, 11 have a results paper linked to the registry record, and 1 did both. The other 21 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Verbal Fluency in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.